July 23, 2017 10:14 PM ET

Biotechnology

Company Overview of OCTIMET Oncology NV

Company Overview

OCTIMET Oncology NV develops MET kinase inhibitors for the treatment of cancer. The company was founded in 2016 and is headquartered in Beerse, Belgium.

Turnhoutseweg 30

Beerse,  2340

Belgium

Founded in 2016

Phone:

32 473 558 353

Key Executives for OCTIMET Oncology NV

Founder and Chief Executive Officer
Founder and CDO
Age: 54
Founder and Scientific Advisor
Founder and CFO
Chief Operating Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
ADx NeuroSciences NV Europe
Apitope International NV Europe
Beta-Cell NV Europe
Bienca S.A. Europe
Biopole S.A. Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
January 18, 2017
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OCTIMET Oncology NV, please visit www.octimet.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.